Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7604)
All Articles published online
|
Publishing Process of This Article
|
Jun 16, 2018 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rungsakulkij N, Suragul W, Mingphruedhi S, Tangtawee P, Muangkaew P, Aeesoa S. Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection. World J Clin Cases 2018; 6(6): 110-120 [PMID: 29988930 DOI: 10.12998/wjcc.v6.i6.110] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i6/110.htm |
| Number | Citing Articles |
| 1 |
Fuqiang Zhang, Lin Zheng, Deyu Li, Hui Yang. To explore the curative effect of CT-guided Iodine-125 radioactive seed implantation in the treatment of stage Ⅳprimary hepatocellular carcinoma. Journal of Interventional Medicine 2021; 4(2): 82 doi: 10.1016/j.jimed.2021.02.009
|
| 2 |
Lei Liang, Ming-Da Wang, Yao-Ming Zhang, Wan-Guang Zhang, Cheng-Wu Zhang, Wan Yee Lau, Feng Shen, Timothy M Pawlik, Dong-Sheng Huang, Tian Yang. Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml). Journal of Hepatocellular Carcinoma 2021; : 103 doi: 10.2147/JHC.S289840
|
| 3 |
Hongyi Yang, Linbin Lu, Wanting Guo, Baocuo Gong, Xuewen Wang, Yaying Chen, Xiong Chen. A Longitudinal Study of AFP Trajectories and Clinical Outcomes in Intermediate-Stage Hepatocellular Carcinoma After Hepatectomy. Journal of Hepatocellular Carcinoma 2024; : 219 doi: 10.2147/JHC.S432011
|
| 4 |
Nobuharu Tamaki, Toshifumi Tada, Masayuki Kurosaki, Yutaka Yasui, Hironori Ochi, Toshie Mashiba, Azusa Sakamoto, Hiroyuki Marusawa, Ryoichi Narita, Yasushi Uchida, Takehiro Akahane, Masahiko Kondo, Nami Mori, Shintaro Takaki, Keiji Tsuji, Haruhiko Kobashi, Atsunori Kusakabe, Koichiro Furuta, Hirotaka Arai, Michiko Nonogi, Chikara Ogawa, Takashi Sato, Takashi Tamada, Shinichiro Nakamura, Chitomi Hasebe, Kaoru Tsuchiya, Namiki Izumi. Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab. Investigational New Drugs 2022; 40(6): 1290 doi: 10.1007/s10637-022-01303-w
|
| 5 |
Linbin Lu, Lujun Shen, Zhixian Wu, Yanhong Shi, Peifeng Hou, Zengfu Xue, Cheng Lin, Xiong Chen. Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study. eClinicalMedicine 2022; 47: 101391 doi: 10.1016/j.eclinm.2022.101391
|
| 6 |
Bo Liu, Xiao Shang, Jin-Yu Shi, Guo-Zhen Cui, Xi Li, Nan-Ya Wang. Early Alpha-Fetoprotein Response Is Associated With Survival in Patients With HBV-Related Hepatocellular Carcinoma Receiving Lenvatinib. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.807189
|
| 7 |
Lea Penzkofer, Jens Mittler, Stefan Heinrich, Nicolas Wachter, Beate Straub, Roman Kloeckner, Fabian Stoehr, Simon Gairing, Fabian Bartsch, Hauke Lang. Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver—A Single Centre Study. Journal of Clinical Medicine 2022; 11(19): 5802 doi: 10.3390/jcm11195802
|
| 8 |
Neal Bhutiani, Stephen J. O'Brien, Erin E. Priddy, Michael E. Egger, Young K. Hong, Megan K. Mercer, Kelly M. McMasters, Robert C.G. Martin, Melissa H. Potts, Charles R. Scoggins. Correlating serum alpha-fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere™). HPB 2020; 22(9): 1330 doi: 10.1016/j.hpb.2019.12.007
|
| 9 |
Xiu-Ping Zhang, Zhen-Hua Chen, Teng-Fei Zhou, Le-Qun Li, Min-Shan Chen, Tian-Fu Wen, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng. A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study. European Journal of Surgical Oncology 2019; 45(9): 1644 doi: 10.1016/j.ejso.2019.03.043
|
| 10 |
Jia-Jia He, Lei Shang, Qun-Wei Yu, Ning Jiao, Shuang Qiu, Wei-Xiong Zhu, Dong-Feng Wu, Yun-Er Tian, Qing Zhang. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World Journal of Gastrointestinal Oncology 2021; 13(7): 716-731 doi: 10.4251/wjgo.v13.i7.716
|
| 11 |
Li-Yue Sun, Wen-Jian Cen, Wen-Ting Tang, Ling Deng, Fang Wang, Xiao-Meng Ji, Jiao-Jiao Yang, Ren-Jing Zhang, Xu-Hui Zhang, Zi-Ming Du, Jie Mei. Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/7640560
|
| 12 |
Yang-Xun Pan, Xu-Qi Sun, Zi-Li Hu, Wa Xie, Ke-Xin Nie, Ai-Ping Fang, Ying-Yao Zhang, Yi-Zhen Fu, Jin-Bin Chen, Jun-Cheng Wang, Xin Wang, Yao-Jun Zhang, Dan-Dan Hu, Min-Shan Chen. Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients. Journal of Hepatocellular Carcinoma 2021; : 657 doi: 10.2147/JHC.S316223
|
| 13 |
Mengling Ji, Hao Zou, Baojun Shu, Guoping Liu, Bingyuan Zhang, Zejiang Xu, Fanfan Pang, Mengxing Cheng, Yafei Sun, Ting Du, Chuandong Sun, Chengzhan Zhu. Prognostic analysis of hepatocellular carcinoma with macrovascular invasion after liver resection and a successful case of conversion therapy. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.1042431
|
| 14 |
Peng-Ji Pan, Jun-Xia Liu. Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma. World Journal of Clinical Cases 2021; 9(22): 6287-6299 doi: 10.12998/wjcc.v9.i22.6287
|
| 15 |
Dong-Hoon Lim, Andrea Casadei-Gardini, Myung Ah Lee, Sara Lonardi, Jin Won Kim, Gianluca Masi, Hong Jae Chon, Margherita Rimini, Ilhwan Kim, Jaekyung Cheon, Jun-Eul Hwang, Jung Hun Kang, Ho Yeong Lim, Changhoon Yoo. Prognostic Implication of Serum AFP in Patients with Hepatocellular Carcinoma Treated with Regorafenib. Future Oncology 2022; 18(27): 3021 doi: 10.2217/fon-2022-0524
|
| 16 |
Rong-yun Mai, Jie Zeng, Wei-da Meng, Hua-ze Lu, Rong Liang, Yan Lin, Guo-bin Wu, Le-qun Li, Liang Ma, Jia-zhou Ye, Tao Bai. Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07969-4
|
| 17 |
Anand Bharathan, V. Sitaram. GI Surgery Annual. GI Surgery Annual 2019; 25: 139 doi: 10.1007/978-981-13-3227-2_5
|
| 18 |
Mingda Wang, Guojun Qian, Hongmei Xiao, Xingkai Liu, Liyang Sun, Zhong Chen, Kongying Lin, Lanqing Yao, Chao Li, Lihui Gu, Jiahao Xu, Xiaodong Sun, Wei Qiu, Timothy M Pawlik, Wan Yee Lau, Guoyue Lv, Feng Shen, Tian Yang. Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients. The Oncologist 2024; doi: 10.1093/oncolo/oyae139
|
| 19 |
Jendrik Becker-Assmann, Mohammad H. Fard-Aghaie, Alexandros Kantas, Georgios Makridis, Tim Reese, Kim C. Wagner, Jörg Petersen, Peter Buggisch, Axel Stang, Thomas von Hahn, Karl J. Oldhafer. Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären Karzinom. Der Chirurg 2020; 91(9): 769 doi: 10.1007/s00104-020-01118-6
|
| 20 |
Ashokachakkaravarthy Kandasamy, Biju Pottakkat. Alpha-fetoprotein: A molecular bootstrap for hepatocellular carcinoma. International Journal of Molecular and Immuno Oncology 2020; 5: 92 doi: 10.25259/IJMIO_5_2020
|
| 21 |
Yu-Liang Huang, Jun-Rong Wu, Min Fang, Hui-Liu Zhao, Zhi-Min Liu, Jian Ye, Ling-Sha Huang, Bo Zhu. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma. Medicine 2019; 98(14): e15090 doi: 10.1097/MD.0000000000015090
|
| 22 |
Jia-Jia He, Lei Shang, Qun-Wei Yu, Ning Jiao, Shuang Qiu, Wei-Xiong Zhu, Dong-Feng Wu, Yun-Er Tian, Qing Zhang. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World Journal of Gastrointestinal Oncology 2021; 13(7): 541 doi: 10.4251/wjgo.v13.i7.541
|
| 23 |
Rabia Ashiq, Batool Fatima, Mohibullah Shah, Dilshad Hussain, Abrar Mohyuddin, Saadat Majeed, Rubaida Mehmood, Muhammad Imran, Muhammad Naeem Ashiq, Muhammad Najam-ul-Haq. Tin derived antimony/nitrogen-doped porous carbon (Sb/NPC) composite for electrochemical sensing of albumin from hepatocellular carcinoma patients. Microchimica Acta 2021; 188(10) doi: 10.1007/s00604-021-05005-7
|
| 24 |
Gang Hou, Bo Liu, Zhong-Qi Fan, Chao Li, Jian-Ping Zhang, Yan-Hui Guo, Ru-Yi Zhang, Yi Zheng, Hong Zhu, Nan-Ya Wang. Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study from China. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1094104
|
| 25 |
Chao He, Wei Peng, Xiaojuan Liu, Chuan Li, Xueting Li, Tian-Fu Wen. Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma. Medicine 2019; 98(31): e16557 doi: 10.1097/MD.0000000000016557
|
| 26 |
Qi Zhao, Yiqiu Xu, Dandan Yuan, Junjun Yang, Ying Wang, Guorong Shen, Xuewen Huang, Nashwa El-Khazragy. Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/9958909
|
| 27 |
Robin Kate Kelley, Tim Meyer, Lorenza Rimassa, Philippe Merle, Joong-Won Park, Thomas Yau, Stephen L. Chan, Jean-Frederic Blanc, Vincent C. Tam, Albert Tran, Vincenzo Dadduzio, David W. Markby, Rajesh Kaldate, Ann-Lii Cheng, Anthony B. El-Khoueiry, Ghassan K. Abou-Alfa. Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research 2020; 26(18): 4795 doi: 10.1158/1078-0432.CCR-19-3884
|
| 28 |
Li-Yue Sun, Wen-Jian Cen, Xin-Xin Zeng, Yu-Yun Zhong, Ling Deng, Jiao-Jiao Yang, Ming Li, Fang Wang. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma. The American Surgeon™ 2024; 90(6): 1240 doi: 10.1177/00031348241227202
|
| 29 |
Xiaojun Hu, Changfeng Li, Qiang Wang, Xueyun Wu, Zhiyu Chen, Feng Xia, Ping Cai, Leida Zhang, Yingfang Fan, Kuansheng Ma. Development and External Validation of a Radiomics Model Derived from Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Histopathologic Grade of Hepatocellular Carcinoma. Diagnostics 2023; 13(3): 413 doi: 10.3390/diagnostics13030413
|